LeMaitre Vascular Total Assets 2007-2019 | LMAT

LeMaitre Vascular total assets from 2007 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
LeMaitre Vascular Annual Total Assets
(Millions of US $)
2018 $153
2017 $126
2016 $102
2015 $91
2014 $81
2013 $70
2012 $63
2011 $60
2010 $63
2009 $57
2008 $54
2007 $61
2006 $57
2005 $25
LeMaitre Vascular Quarterly Total Assets
(Millions of US $)
Q1 2019 $160
Q4 2018 $153
Q3 2018 $144
Q2 2018 $137
Q1 2018 $129
Q4 2017 $126
Q3 2017 $121
Q2 2017 $112
Q1 2017 $107
Q4 2016 $102
Q3 2016 $101
Q2 2016 $96
Q1 2016 $93
Q4 2015 $91
Q3 2015 $87
Q2 2015 $83
Q1 2015 $80
Q4 2014 $81
Q3 2014 $84
Q2 2014 $81
Q1 2014 $69
Q4 2013 $70
Q3 2013 $67
Q2 2013 $64
Q1 2013 $63
Q4 2012 $63
Q3 2012 $61
Q2 2012 $60
Q1 2012 $59
Q4 2011 $60
Q3 2011 $63
Q2 2011 $62
Q1 2011 $61
Q4 2010 $63
Q3 2010 $61
Q2 2010 $58
Q1 2010 $57
Q4 2009 $57
Q3 2009 $56
Q2 2009 $54
Q1 2009 $51
Q4 2008 $54
Q3 2008 $54
Q2 2008 $56
Q1 2008 $57
Q4 2007 $61
Q3 2007 $57
Q2 2007 $56
Q1 2007 $56
Q4 2006 $57
Q2 2006 $0
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.545B $0.106B
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $149.955B 29.11
Medtronic (MDT) Ireland $133.284B 19.04
Stryker (SYK) United States $75.636B 26.99
Boston Scientific (BSX) United States $57.976B 27.79
Baxter (BAX) United States $42.043B 26.50
Zimmer Biomet Holdings (ZBH) United States $24.226B 15.56
Smith & Nephew SNATS (SNN) United Kingdom $19.156B 0.00
ResMed (RMD) United States $17.217B 32.90
Canopy Growth (CGC) Canada $13.835B 0.00
Bio-Rad Laboratories (BIO) United States $9.076B 48.12
Aurora Cannabis (ACB) Canada $7.403B 73.00
Insulet (PODD) United States $7.147B 520.74
Hill-Rom Holdings (HRC) United States $6.992B 21.20
Perrigo (PRGO) Ireland $6.052B 10.23
Haemonetics (HAE) United States $6.021B 49.14
GW Pharmaceuticals (GWPH) United Kingdom $5.237B 0.00
ICU Medical (ICUI) United States $5.130B 30.61
Hutchison China MediTech (HCM) China $3.814B 0.00
Neogen (NEOG) United States $3.238B 52.65
Agios Pharmaceuticals (AGIO) United States $2.981B 0.00
NuVasive (NUVA) United States $2.962B 24.19
National Vision Holdings (EYE) United States $2.499B 53.25
Quidel (QDEL) United States $2.360B 24.49
Aphria (APHA) $1.687B 0.00
Cardiovascular Systems (CSII) United States $1.495B 858.80
Phibro Animal Health (PAHC) United States $1.220B 18.28
AtriCure (ATRC) United States $1.159B 0.00
VAREX IMAGING (VREX) United States $1.119B 23.75
Lantheus Holdings (LNTH) United States $1.081B 28.71
OrganiGram Holdings (OGI) Canada $0.993B 0.00
NanoString Technologies (NSTG) United States $0.935B 0.00
PetIQ (PETQ) United States $0.899B 21.84
Quanterix (QTRX) United States $0.846B 0.00
MacroGenics (MGNX) United States $0.812B 0.00
Omeros (OMER) United States $0.794B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.771B 21.61
Cerus (CERS) United States $0.682B 0.00
TG Therapeutics (TGTX) United States $0.638B 0.00
Surmodics (SRDX) United States $0.572B 83.20
OraSure Technologies (OSUR) United States $0.552B 25.40
Meridian Bioscience (VIVO) United States $0.489B 14.95
Evolus (EOLS) United States $0.371B 0.00
Vapotherm (VAPO) United States $0.364B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.355B 0.00
Zynex (ZYXI) United States $0.355B 36.73
BioLife Solutions (BLFS) United States $0.311B 97.41
Utah Medical Products (UTMD) United States $0.302B 20.93
Bovie Medical (APYX) United States $0.217B 0.00
Cytosorbents (CTSO) United States $0.210B 0.00
Owens & Minor (OMI) United States $0.193B 4.08
Chimerix (CMRX) United States $0.173B 0.00
Rockwell Medical (RMTI) United States $0.172B 0.00
Fonar (FONR) United States $0.140B 7.38
Female Health (VERU) United States $0.134B 0.00
BRAINSWAY LTD (BWAY) Israel $0.111B 0.00
Neurotrope (NTRP) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.100B 0.00
Surface Oncology (SURF) United States $0.088B 0.00
United-Guardian (UG) United States $0.087B 19.21
Oramed Pharmaceuticals (ORMP) United States $0.062B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
Senestech (SNES) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.039B 13.58
Conatus Pharmaceuticals (CNAT) United States $0.031B 0.00
GUARDION HEALTH (GHSI) United States $0.030B 0.00
Cellectar Biosciences (CLRB) United States $0.021B 0.00
Valeritas Holdings (VLRX) United States $0.015B 0.00
Capricor Therapeutics (CAPR) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.007B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 3.73